Global Devic’s Syndrome (Neuromyelitis Optica) Treatment Industry Research Report 2020, Forecast to 2025
The report requires updating with new data and is sent in 48 hours after order is placed.
The Devic’s Syndrome (Neuromyelitis Optica) Treatment market was valued at US$ xx in 2019, prior to COVID-19. Whereas post-COVID-19 scenario, the market for Devic’s Syndrome (Neuromyelitis Optica) Treatment is projected to grow from US$ xx million in 2020, and is projected to reach xx by 2025, at a CAGR of xx% during the forecast period. Projected and forecast revenue values are in constant U.S. dollars, unadjusted for inflation. Product values are estimated based on manufacturers' revenue.
The report offers detailed coverage of Devic’s Syndrome (Neuromyelitis Optica) Treatment industry and main market trends. The market research includes historical and forecast market data, demand, application details, price trends, and company shares of the leading Devic’s Syndrome (Neuromyelitis Optica) Treatment by geography. The report splits the market size, by volume and value, on the basis of application type and geography.
In addition to this data, the report provides insight into drivers of market demand and strategies of suppliers. Key players are profiled, and their market shares in the global Devic’s Syndrome (Neuromyelitis Optica) Treatment market are discussed.
The market is segmented by types:
Finally, the report provides detailed profile and data information analysis of leading company.
The Devic’s Syndrome (Neuromyelitis Optica) Treatment market was valued at US$ xx in 2019, prior to COVID-19. Whereas post-COVID-19 scenario, the market for Devic’s Syndrome (Neuromyelitis Optica) Treatment is projected to grow from US$ xx million in 2020, and is projected to reach xx by 2025, at a CAGR of xx% during the forecast period. Projected and forecast revenue values are in constant U.S. dollars, unadjusted for inflation. Product values are estimated based on manufacturers' revenue.
The report offers detailed coverage of Devic’s Syndrome (Neuromyelitis Optica) Treatment industry and main market trends. The market research includes historical and forecast market data, demand, application details, price trends, and company shares of the leading Devic’s Syndrome (Neuromyelitis Optica) Treatment by geography. The report splits the market size, by volume and value, on the basis of application type and geography.
In addition to this data, the report provides insight into drivers of market demand and strategies of suppliers. Key players are profiled, and their market shares in the global Devic’s Syndrome (Neuromyelitis Optica) Treatment market are discussed.
The market is segmented by types:
- Eculizumab
- Methylprednisolone
- Azathioprine
- Mycophenolate Mofetil
- Rituximab
- Hospitals
- Clinic
- Others
Finally, the report provides detailed profile and data information analysis of leading company.
- Alexion Pharmaceuticals, Inc.
- Sandoz Inc. (Novartis)
- Pharmacia & Upjohn (a subsidary of Pfizer)
- Teva Pharmaceuticals
- Zydus Pharmaceuticals, Inc.
- Fresenius Kabi AG
- Mylan Pharmaceuticals, Inc.
- Sagent Pharmaceuticals, Inc.
- Lupin Ltd.
- Alkem Laboratories Ltd.
- Hoffmann-La Roche/ Chugai Pharmaceutical
- MedImmune LLC
- RemeGen, Ltd.
- xx data tables and xx additional tables
- An overview of global Devic’s Syndrome (Neuromyelitis Optica) Treatment market
- An detailed key players analysis across regions
- Analyses of global market trends, with historical data, estimates for 2020 and projections of compound annual growth rates (CAGRs) through 2025
- Insights into regulatory and environmental developments
- Information on the supply and demand scenario and evaluation of technological and investment opportunities in the Devic’s Syndrome (Neuromyelitis Optica) Treatment market
- Profiles of major players in the industry, including%li% Alexion Pharmaceuticals, Inc., Sandoz Inc. (Novartis), Pharmacia & Upjohn (a subsidary of Pfizer), Teva Pharmaceuticals, Zydus Pharmaceuticals, Inc......
- To study and analyze the global Devic’s Syndrome (Neuromyelitis Optica) Treatment consumption (value & volume) by key regions/countries, product type and application, history data from 2015 to 2019, and forecast to 2025.
- To understand the structure of Devic’s Syndrome (Neuromyelitis Optica) Treatment market by identifying its various subsegments.
- Focuses on the key global Devic’s Syndrome (Neuromyelitis Optica) Treatment manufacturers, to define, describe and analyze the sales volume, value, market share, market competition landscape, Porter's five forces analysis, SWOT analysis and development plans in next few years.
- To analyze the Devic’s Syndrome (Neuromyelitis Optica) Treatment with respect to individual growth trends, future prospects, and their contribution to the total market.
- To share detailed information about the key factors influencing the growth of the market (growth potential, opportunities, drivers, industry-specific challenges and risks).
- To project the consumption of Devic’s Syndrome (Neuromyelitis Optica) Treatment submarkets, with respect to key regions (along with their respective key countries).
- To analyze competitive developments such as expansions, agreements, new product launches, and acquisitions in the market.
- To strategically profile the key players and comprehensively analyze their growth strategies.
Global Devic’s Syndrome (Neuromyelitis Optica) Treatment Market Report 2020, Forecast to 2025
1 SCOPE OF THE STUDY
1.1 Devic’s Syndrome (Neuromyelitis Optica) Treatment Introduction
1.2 Research Programs
1.3 Analysis of Macroeconomic Indicators
1.4 Years Considered
1.5 Methodology
1.6 Data Source
1.7 Research Objectives
2 DEVIC’S SYNDROME (NEUROMYELITIS OPTICA) TREATMENT INDUSTRY OVERVIEW
2.1 Global Devic’s Syndrome (Neuromyelitis Optica) Treatment Market Size (Million USD) Comparison by Regions (2020-2025)
2.1.1 Devic’s Syndrome (Neuromyelitis Optica) Treatment Global Import Market Analysis
2.1.2 Devic’s Syndrome (Neuromyelitis Optica) Treatment Global Export Market Analysis
2.1.3 Devic’s Syndrome (Neuromyelitis Optica) Treatment Global Main Region Market Analysis
2.2 Market Analysis by Type
2.2.1 Eculizumab
2.2.2 Methylprednisolone
2.2.3 Azathioprine
2.2.4 Mycophenolate Mofetil
2.2.5 Rituximab
2.3 Market Analysis by Application
2.3.1 Hospitals
2.3.2 Clinic
2.3.3 Others
2.4 Global Devic’s Syndrome (Neuromyelitis Optica) Treatment Revenue, Sales and Market Share by Manufacturer
2.4.1 Global Devic’s Syndrome (Neuromyelitis Optica) Treatment Sales and Market Share by Manufacturer (2018-2020)
2.4.2 Global Devic’s Syndrome (Neuromyelitis Optica) Treatment Revenue and Market Share by Manufacturer (2018-2020)
2.4.3 Global Devic’s Syndrome (Neuromyelitis Optica) Treatment Industry Concentration Ratio (CR5 and HHI)
2.4.4 Top 5 Devic’s Syndrome (Neuromyelitis Optica) Treatment Manufacturer Market Share
2.4.5 Top 10 Devic’s Syndrome (Neuromyelitis Optica) Treatment Manufacturer Market Share
2.4.6 Date of Key Manufacturers Enter into Devic’s Syndrome (Neuromyelitis Optica) Treatment Market
2.4.7 Key Manufacturers Devic’s Syndrome (Neuromyelitis Optica) Treatment Product Offered
2.4.8 Mergers & Acquisitions Planning
2.5 Devic’s Syndrome (Neuromyelitis Optica) Treatment Historical Development Overview
2.6 Market Dynamics
2.6.1 Market Opportunities
2.6.2 Market Risk
2.6.3 Market Driving Force
2.6.4 Porter's Five Forces Analysis
2.7 Coronavirus Disease 2019 (Covid-19): Devic’s Syndrome (Neuromyelitis Optica) Treatment Industry Impact
2.7.1 How the Covid-19 is Affecting the Devic’s Syndrome (Neuromyelitis Optica) Treatment Industry
2.7.2 Devic’s Syndrome (Neuromyelitis Optica) Treatment Business Impact Assessment - Covid-19
2.7.3 Market Trends and Devic’s Syndrome (Neuromyelitis Optica) Treatment Potential Opportunities in the COVID-19 Landscape
2.7.4 Measures / Proposal against Covid-19
3 UPSTREAM AND DOWNSTREAM MARKET ANALYSIS
3.1 Upstream Analysis
3.1.1 Macro Analysis of Upstream Markets
3.1.2 Key Players in Upstream Markets
3.1.3 Upstream Market Trend Analysis
3.1.4 Devic’s Syndrome (Neuromyelitis Optica) Treatment Manufacturing Cost Analysis
3.2 Downstream Market Analysis
3.2.1 Macro Analysis of Down Markets
3.2.2 Key Players in Down Markets
3.2.3 Downstream Market Trend Analysis
3.2.4 Sales Channel, Distributors, Traders and Dealers
4 GLOBAL DEVIC’S SYNDROME (NEUROMYELITIS OPTICA) TREATMENT MARKET SIZE CATEGORIZED BY REGIONS (2015-2020)
4.1 Global Devic’s Syndrome (Neuromyelitis Optica) Treatment Sales Market Share by Region
4.2 Global Devic’s Syndrome (Neuromyelitis Optica) Treatment Revenue Market Share by Region (2015-2019)
4.3 Global Devic’s Syndrome (Neuromyelitis Optica) Treatment Sales, Revenue, Price and Gross Margin (2015-2020)
4.4 North America Devic’s Syndrome (Neuromyelitis Optica) Treatment Market Size Detail
4.4.1 North America Devic’s Syndrome (Neuromyelitis Optica) Treatment Sales Growth Rate (2015-2020)
4.4.2 North America Devic’s Syndrome (Neuromyelitis Optica) Treatment Sales, Revenue, Price and Gross Margin (2015-2020)
4.5 Europe Devic’s Syndrome (Neuromyelitis Optica) Treatment Market Size Detail
4.5.1 Europe Devic’s Syndrome (Neuromyelitis Optica) Treatment Sales Growth Rate (2015-2020)
4.5.2 Europe Devic’s Syndrome (Neuromyelitis Optica) Treatment Sales, Revenue, Price and Gross Margin (2015-2020)
4.6 Japan Devic’s Syndrome (Neuromyelitis Optica) Treatment Market Size Detail
4.6.1 Japan Devic’s Syndrome (Neuromyelitis Optica) Treatment Sales Growth Rate (2015-2020)
4.6.2 Japan Devic’s Syndrome (Neuromyelitis Optica) Treatment Sales, Revenue, Price and Gross Margin (2015-2020)
4.7 China Devic’s Syndrome (Neuromyelitis Optica) Treatment Market Size Detail
4.7.1 China Devic’s Syndrome (Neuromyelitis Optica) Treatment Sales Growth Rate (2015-2020)
4.7.2 China Devic’s Syndrome (Neuromyelitis Optica) Treatment Sales, Revenue, Price and Gross Margin (2015-2020)
5 GLOBAL DEVIC’S SYNDROME (NEUROMYELITIS OPTICA) TREATMENT MARKET SEGMENT BY TYPE
5.1 Global Devic’s Syndrome (Neuromyelitis Optica) Treatment Revenue, Sales and Market Share by Type (2015-2020)
5.1.1 Global Devic’s Syndrome (Neuromyelitis Optica) Treatment Sales and Market Share by Type (2015-2020)
5.1.2 Global Devic’s Syndrome (Neuromyelitis Optica) Treatment Revenue and Market Share by Type (2015-2020)
5.2 Eculizumab Sales Growth Rate and Price
5.2.1 Global Eculizumab Sales Growth Rate (2015-2020)
5.2.2 Global Eculizumab Price (2015-2020)
5.3 Methylprednisolone Sales Growth Rate and Price
5.3.1 Global Methylprednisolone Sales Growth Rate (2015-2020)
5.3.2 Global Methylprednisolone Price (2015-2020)
5.4 Azathioprine Sales Growth Rate and Price
5.4.1 Global Azathioprine Sales Growth Rate (2015-2020)
5.4.2 Global Azathioprine Price (2015-2020)
5.5 Mycophenolate Mofetil Sales Growth Rate and Price
5.5.1 Global Mycophenolate Mofetil Sales Growth Rate (2015-2020)
5.5.2 Global Mycophenolate Mofetil Price (2015-2020)
5.6 Rituximab Sales Growth Rate and Price
5.6.1 Global Rituximab Sales Growth Rate (2015-2020)
5.6.2 Global Rituximab Price (2015-2020)
6 GLOBAL DEVIC’S SYNDROME (NEUROMYELITIS OPTICA) TREATMENT MARKET SEGMENT BY APPLICATION
6.1 Global Devic’s Syndrome (Neuromyelitis Optica) TreatmentSales Market Share by Application (2015-2020)
6.2 Hospitals Sales Growth Rate (2015-2020)
6.3 Clinic Sales Growth Rate (2015-2020)
6.4 Others Sales Growth Rate (2015-2020)
7 GLOBAL DEVIC’S SYNDROME (NEUROMYELITIS OPTICA) TREATMENT MARKET FORECAST
7.1 Global Devic’s Syndrome (Neuromyelitis Optica) Treatment Sales, Revenue Forecast
7.1.1 Global Devic’s Syndrome (Neuromyelitis Optica) Treatment Sales Growth Rate Forecast (2020-2025)
7.1.2 Global Devic’s Syndrome (Neuromyelitis Optica) Treatment Revenue and Growth Rate Forecast (2020-2025)
7.1.3 Global Devic’s Syndrome (Neuromyelitis Optica) Treatment Price and Trend Forecast (2020-2025)
7.2 Global Devic’s Syndrome (Neuromyelitis Optica) Treatment Sales Forecast by Region (2020-2025)
7.2.1 North America Devic’s Syndrome (Neuromyelitis Optica) Treatment Sales, Revenue Forecast (2020-2025)
7.2.2 Europe Devic’s Syndrome (Neuromyelitis Optica) Treatment Sales, Revenue Forecast (2020-2025)
7.2.3 Japan Devic’s Syndrome (Neuromyelitis Optica) Treatment Production, Revenue Forecast (2020-2025)
7.2.4 China Devic’s Syndrome (Neuromyelitis Optica) Treatment Production, Revenue Forecast (2020-2025)
8 ANALYSIS OF DEVIC’S SYNDROME (NEUROMYELITIS OPTICA) TREATMENT INDUSTRY KEY MANUFACTURERS
8.1 Alexion Pharmaceuticals, Inc.
8.1.1 Company Details
8.1.2 Product Information
8.1.3 Alexion Pharmaceuticals, Inc. Devic’s Syndrome (Neuromyelitis Optica) Treatment Production, Price, Cost, Gross Margin, and Revenue (2018-2020)
8.1.4 Main Business Overview
8.1.5 Alexion Pharmaceuticals, Inc. News
8.2 Sandoz Inc. (Novartis)
8.2.1 Company Details
8.2.2 Product Information
8.2.3 Sandoz Inc. (Novartis) Devic’s Syndrome (Neuromyelitis Optica) Treatment Production, Price, Cost, Gross Margin, and Revenue (2018-2020)
8.2.4 Main Business Overview
8.2.5 Sandoz Inc. (Novartis) News
8.3 Pharmacia & Upjohn (a subsidary of Pfizer)
8.3.1 Company Details
8.3.2 Product Information
8.3.3 Pharmacia & Upjohn (a subsidary of Pfizer) Devic’s Syndrome (Neuromyelitis Optica) Treatment Production, Price, Cost, Gross Margin, and Revenue (2018-2020)
8.3.4 Main Business Overview
8.3.5 Pharmacia & Upjohn (a subsidary of Pfizer) News
8.4 Teva Pharmaceuticals
8.4.1 Company Details
8.4.2 Product Information
8.4.3 Teva Pharmaceuticals Devic’s Syndrome (Neuromyelitis Optica) Treatment Production, Price, Cost, Gross Margin, and Revenue (2018-2020)
8.4.4 Main Business Overview
8.4.5 Teva Pharmaceuticals News
8.5 Zydus Pharmaceuticals, Inc.
8.5.1 Company Details
8.5.2 Product Information
8.5.3 Zydus Pharmaceuticals, Inc. Devic’s Syndrome (Neuromyelitis Optica) Treatment Production, Price, Cost, Gross Margin, and Revenue (2018-2020)
8.5.4 Main Business Overview
8.5.5 Zydus Pharmaceuticals, Inc. News
8.6 Fresenius Kabi AG
8.6.1 Company Details
8.6.2 Product Information
8.6.3 Fresenius Kabi AG Devic’s Syndrome (Neuromyelitis Optica) Treatment Production, Price, Cost, Gross Margin, and Revenue (2018-2020)
8.6.4 Main Business Overview
8.6.5 Fresenius Kabi AG News
8.7 Mylan Pharmaceuticals, Inc.
8.7.1 Company Details
8.7.2 Product Information
8.7.3 Mylan Pharmaceuticals, Inc. Devic’s Syndrome (Neuromyelitis Optica) Treatment Production, Price, Cost, Gross Margin, and Revenue (2018-2020)
8.7.4 Main Business Overview
8.7.5 Mylan Pharmaceuticals, Inc. News
8.8 Sagent Pharmaceuticals, Inc.
8.8.1 Company Details
8.8.2 Product Information
8.8.3 Sagent Pharmaceuticals, Inc. Devic’s Syndrome (Neuromyelitis Optica) Treatment Production, Price, Cost, Gross Margin, and Revenue (2018-2020)
8.8.4 Main Business Overview
8.8.5 Sagent Pharmaceuticals, Inc. News
8.9 Lupin Ltd.
8.9.1 Company Details
8.9.2 Product Information
8.9.3 Lupin Ltd. Devic’s Syndrome (Neuromyelitis Optica) Treatment Production, Price, Cost, Gross Margin, and Revenue (2018-2020)
8.9.4 Main Business Overview
8.9.5 Lupin Ltd. News
8.10 Alkem Laboratories Ltd.
8.10.1 Company Details
8.10.2 Product Information
8.10.3 Alkem Laboratories Ltd. Devic’s Syndrome (Neuromyelitis Optica) Treatment Production, Price, Cost, Gross Margin, and Revenue (2018-2020)
8.10.4 Main Business Overview
8.10.5 Alkem Laboratories Ltd. News
8.11 Hoffmann-La Roche/ Chugai Pharmaceutical
8.11.1 Company Details
8.11.2 Product Information
8.11.3 Hoffmann-La Roche/ Chugai Pharmaceutical Devic’s Syndrome (Neuromyelitis Optica) Treatment Production, Price, Cost, Gross Margin, and Revenue (2018-2020)
8.11.4 Main Business Overview
8.11.5 Hoffmann-La Roche/ Chugai Pharmaceutical News
8.12 MedImmune LLC
8.12.1 Company Details
8.12.2 Product Information
8.12.3 MedImmune LLC Devic’s Syndrome (Neuromyelitis Optica) Treatment Production, Price, Cost, Gross Margin, and Revenue (2018-2020)
8.12.4 Main Business Overview
8.12.5 MedImmune LLC News
8.13 RemeGen, Ltd.
8.13.1 Company Details
8.13.2 Product Information
8.13.3 RemeGen, Ltd. Devic’s Syndrome (Neuromyelitis Optica) Treatment Production, Price, Cost, Gross Margin, and Revenue (2018-2020)
8.13.4 Main Business Overview
8.13.5 RemeGen, Ltd. News
9 RESEARCH FINDINGS AND CONCLUSION
10 APPENDIX
1 SCOPE OF THE STUDY
1.1 Devic’s Syndrome (Neuromyelitis Optica) Treatment Introduction
1.2 Research Programs
1.3 Analysis of Macroeconomic Indicators
1.4 Years Considered
1.5 Methodology
1.6 Data Source
1.7 Research Objectives
2 DEVIC’S SYNDROME (NEUROMYELITIS OPTICA) TREATMENT INDUSTRY OVERVIEW
2.1 Global Devic’s Syndrome (Neuromyelitis Optica) Treatment Market Size (Million USD) Comparison by Regions (2020-2025)
2.1.1 Devic’s Syndrome (Neuromyelitis Optica) Treatment Global Import Market Analysis
2.1.2 Devic’s Syndrome (Neuromyelitis Optica) Treatment Global Export Market Analysis
2.1.3 Devic’s Syndrome (Neuromyelitis Optica) Treatment Global Main Region Market Analysis
2.2 Market Analysis by Type
2.2.1 Eculizumab
2.2.2 Methylprednisolone
2.2.3 Azathioprine
2.2.4 Mycophenolate Mofetil
2.2.5 Rituximab
2.3 Market Analysis by Application
2.3.1 Hospitals
2.3.2 Clinic
2.3.3 Others
2.4 Global Devic’s Syndrome (Neuromyelitis Optica) Treatment Revenue, Sales and Market Share by Manufacturer
2.4.1 Global Devic’s Syndrome (Neuromyelitis Optica) Treatment Sales and Market Share by Manufacturer (2018-2020)
2.4.2 Global Devic’s Syndrome (Neuromyelitis Optica) Treatment Revenue and Market Share by Manufacturer (2018-2020)
2.4.3 Global Devic’s Syndrome (Neuromyelitis Optica) Treatment Industry Concentration Ratio (CR5 and HHI)
2.4.4 Top 5 Devic’s Syndrome (Neuromyelitis Optica) Treatment Manufacturer Market Share
2.4.5 Top 10 Devic’s Syndrome (Neuromyelitis Optica) Treatment Manufacturer Market Share
2.4.6 Date of Key Manufacturers Enter into Devic’s Syndrome (Neuromyelitis Optica) Treatment Market
2.4.7 Key Manufacturers Devic’s Syndrome (Neuromyelitis Optica) Treatment Product Offered
2.4.8 Mergers & Acquisitions Planning
2.5 Devic’s Syndrome (Neuromyelitis Optica) Treatment Historical Development Overview
2.6 Market Dynamics
2.6.1 Market Opportunities
2.6.2 Market Risk
2.6.3 Market Driving Force
2.6.4 Porter's Five Forces Analysis
2.7 Coronavirus Disease 2019 (Covid-19): Devic’s Syndrome (Neuromyelitis Optica) Treatment Industry Impact
2.7.1 How the Covid-19 is Affecting the Devic’s Syndrome (Neuromyelitis Optica) Treatment Industry
2.7.2 Devic’s Syndrome (Neuromyelitis Optica) Treatment Business Impact Assessment - Covid-19
2.7.3 Market Trends and Devic’s Syndrome (Neuromyelitis Optica) Treatment Potential Opportunities in the COVID-19 Landscape
2.7.4 Measures / Proposal against Covid-19
3 UPSTREAM AND DOWNSTREAM MARKET ANALYSIS
3.1 Upstream Analysis
3.1.1 Macro Analysis of Upstream Markets
3.1.2 Key Players in Upstream Markets
3.1.3 Upstream Market Trend Analysis
3.1.4 Devic’s Syndrome (Neuromyelitis Optica) Treatment Manufacturing Cost Analysis
3.2 Downstream Market Analysis
3.2.1 Macro Analysis of Down Markets
3.2.2 Key Players in Down Markets
3.2.3 Downstream Market Trend Analysis
3.2.4 Sales Channel, Distributors, Traders and Dealers
4 GLOBAL DEVIC’S SYNDROME (NEUROMYELITIS OPTICA) TREATMENT MARKET SIZE CATEGORIZED BY REGIONS (2015-2020)
4.1 Global Devic’s Syndrome (Neuromyelitis Optica) Treatment Sales Market Share by Region
4.2 Global Devic’s Syndrome (Neuromyelitis Optica) Treatment Revenue Market Share by Region (2015-2019)
4.3 Global Devic’s Syndrome (Neuromyelitis Optica) Treatment Sales, Revenue, Price and Gross Margin (2015-2020)
4.4 North America Devic’s Syndrome (Neuromyelitis Optica) Treatment Market Size Detail
4.4.1 North America Devic’s Syndrome (Neuromyelitis Optica) Treatment Sales Growth Rate (2015-2020)
4.4.2 North America Devic’s Syndrome (Neuromyelitis Optica) Treatment Sales, Revenue, Price and Gross Margin (2015-2020)
4.5 Europe Devic’s Syndrome (Neuromyelitis Optica) Treatment Market Size Detail
4.5.1 Europe Devic’s Syndrome (Neuromyelitis Optica) Treatment Sales Growth Rate (2015-2020)
4.5.2 Europe Devic’s Syndrome (Neuromyelitis Optica) Treatment Sales, Revenue, Price and Gross Margin (2015-2020)
4.6 Japan Devic’s Syndrome (Neuromyelitis Optica) Treatment Market Size Detail
4.6.1 Japan Devic’s Syndrome (Neuromyelitis Optica) Treatment Sales Growth Rate (2015-2020)
4.6.2 Japan Devic’s Syndrome (Neuromyelitis Optica) Treatment Sales, Revenue, Price and Gross Margin (2015-2020)
4.7 China Devic’s Syndrome (Neuromyelitis Optica) Treatment Market Size Detail
4.7.1 China Devic’s Syndrome (Neuromyelitis Optica) Treatment Sales Growth Rate (2015-2020)
4.7.2 China Devic’s Syndrome (Neuromyelitis Optica) Treatment Sales, Revenue, Price and Gross Margin (2015-2020)
5 GLOBAL DEVIC’S SYNDROME (NEUROMYELITIS OPTICA) TREATMENT MARKET SEGMENT BY TYPE
5.1 Global Devic’s Syndrome (Neuromyelitis Optica) Treatment Revenue, Sales and Market Share by Type (2015-2020)
5.1.1 Global Devic’s Syndrome (Neuromyelitis Optica) Treatment Sales and Market Share by Type (2015-2020)
5.1.2 Global Devic’s Syndrome (Neuromyelitis Optica) Treatment Revenue and Market Share by Type (2015-2020)
5.2 Eculizumab Sales Growth Rate and Price
5.2.1 Global Eculizumab Sales Growth Rate (2015-2020)
5.2.2 Global Eculizumab Price (2015-2020)
5.3 Methylprednisolone Sales Growth Rate and Price
5.3.1 Global Methylprednisolone Sales Growth Rate (2015-2020)
5.3.2 Global Methylprednisolone Price (2015-2020)
5.4 Azathioprine Sales Growth Rate and Price
5.4.1 Global Azathioprine Sales Growth Rate (2015-2020)
5.4.2 Global Azathioprine Price (2015-2020)
5.5 Mycophenolate Mofetil Sales Growth Rate and Price
5.5.1 Global Mycophenolate Mofetil Sales Growth Rate (2015-2020)
5.5.2 Global Mycophenolate Mofetil Price (2015-2020)
5.6 Rituximab Sales Growth Rate and Price
5.6.1 Global Rituximab Sales Growth Rate (2015-2020)
5.6.2 Global Rituximab Price (2015-2020)
6 GLOBAL DEVIC’S SYNDROME (NEUROMYELITIS OPTICA) TREATMENT MARKET SEGMENT BY APPLICATION
6.1 Global Devic’s Syndrome (Neuromyelitis Optica) TreatmentSales Market Share by Application (2015-2020)
6.2 Hospitals Sales Growth Rate (2015-2020)
6.3 Clinic Sales Growth Rate (2015-2020)
6.4 Others Sales Growth Rate (2015-2020)
7 GLOBAL DEVIC’S SYNDROME (NEUROMYELITIS OPTICA) TREATMENT MARKET FORECAST
7.1 Global Devic’s Syndrome (Neuromyelitis Optica) Treatment Sales, Revenue Forecast
7.1.1 Global Devic’s Syndrome (Neuromyelitis Optica) Treatment Sales Growth Rate Forecast (2020-2025)
7.1.2 Global Devic’s Syndrome (Neuromyelitis Optica) Treatment Revenue and Growth Rate Forecast (2020-2025)
7.1.3 Global Devic’s Syndrome (Neuromyelitis Optica) Treatment Price and Trend Forecast (2020-2025)
7.2 Global Devic’s Syndrome (Neuromyelitis Optica) Treatment Sales Forecast by Region (2020-2025)
7.2.1 North America Devic’s Syndrome (Neuromyelitis Optica) Treatment Sales, Revenue Forecast (2020-2025)
7.2.2 Europe Devic’s Syndrome (Neuromyelitis Optica) Treatment Sales, Revenue Forecast (2020-2025)
7.2.3 Japan Devic’s Syndrome (Neuromyelitis Optica) Treatment Production, Revenue Forecast (2020-2025)
7.2.4 China Devic’s Syndrome (Neuromyelitis Optica) Treatment Production, Revenue Forecast (2020-2025)
8 ANALYSIS OF DEVIC’S SYNDROME (NEUROMYELITIS OPTICA) TREATMENT INDUSTRY KEY MANUFACTURERS
8.1 Alexion Pharmaceuticals, Inc.
8.1.1 Company Details
8.1.2 Product Information
8.1.3 Alexion Pharmaceuticals, Inc. Devic’s Syndrome (Neuromyelitis Optica) Treatment Production, Price, Cost, Gross Margin, and Revenue (2018-2020)
8.1.4 Main Business Overview
8.1.5 Alexion Pharmaceuticals, Inc. News
8.2 Sandoz Inc. (Novartis)
8.2.1 Company Details
8.2.2 Product Information
8.2.3 Sandoz Inc. (Novartis) Devic’s Syndrome (Neuromyelitis Optica) Treatment Production, Price, Cost, Gross Margin, and Revenue (2018-2020)
8.2.4 Main Business Overview
8.2.5 Sandoz Inc. (Novartis) News
8.3 Pharmacia & Upjohn (a subsidary of Pfizer)
8.3.1 Company Details
8.3.2 Product Information
8.3.3 Pharmacia & Upjohn (a subsidary of Pfizer) Devic’s Syndrome (Neuromyelitis Optica) Treatment Production, Price, Cost, Gross Margin, and Revenue (2018-2020)
8.3.4 Main Business Overview
8.3.5 Pharmacia & Upjohn (a subsidary of Pfizer) News
8.4 Teva Pharmaceuticals
8.4.1 Company Details
8.4.2 Product Information
8.4.3 Teva Pharmaceuticals Devic’s Syndrome (Neuromyelitis Optica) Treatment Production, Price, Cost, Gross Margin, and Revenue (2018-2020)
8.4.4 Main Business Overview
8.4.5 Teva Pharmaceuticals News
8.5 Zydus Pharmaceuticals, Inc.
8.5.1 Company Details
8.5.2 Product Information
8.5.3 Zydus Pharmaceuticals, Inc. Devic’s Syndrome (Neuromyelitis Optica) Treatment Production, Price, Cost, Gross Margin, and Revenue (2018-2020)
8.5.4 Main Business Overview
8.5.5 Zydus Pharmaceuticals, Inc. News
8.6 Fresenius Kabi AG
8.6.1 Company Details
8.6.2 Product Information
8.6.3 Fresenius Kabi AG Devic’s Syndrome (Neuromyelitis Optica) Treatment Production, Price, Cost, Gross Margin, and Revenue (2018-2020)
8.6.4 Main Business Overview
8.6.5 Fresenius Kabi AG News
8.7 Mylan Pharmaceuticals, Inc.
8.7.1 Company Details
8.7.2 Product Information
8.7.3 Mylan Pharmaceuticals, Inc. Devic’s Syndrome (Neuromyelitis Optica) Treatment Production, Price, Cost, Gross Margin, and Revenue (2018-2020)
8.7.4 Main Business Overview
8.7.5 Mylan Pharmaceuticals, Inc. News
8.8 Sagent Pharmaceuticals, Inc.
8.8.1 Company Details
8.8.2 Product Information
8.8.3 Sagent Pharmaceuticals, Inc. Devic’s Syndrome (Neuromyelitis Optica) Treatment Production, Price, Cost, Gross Margin, and Revenue (2018-2020)
8.8.4 Main Business Overview
8.8.5 Sagent Pharmaceuticals, Inc. News
8.9 Lupin Ltd.
8.9.1 Company Details
8.9.2 Product Information
8.9.3 Lupin Ltd. Devic’s Syndrome (Neuromyelitis Optica) Treatment Production, Price, Cost, Gross Margin, and Revenue (2018-2020)
8.9.4 Main Business Overview
8.9.5 Lupin Ltd. News
8.10 Alkem Laboratories Ltd.
8.10.1 Company Details
8.10.2 Product Information
8.10.3 Alkem Laboratories Ltd. Devic’s Syndrome (Neuromyelitis Optica) Treatment Production, Price, Cost, Gross Margin, and Revenue (2018-2020)
8.10.4 Main Business Overview
8.10.5 Alkem Laboratories Ltd. News
8.11 Hoffmann-La Roche/ Chugai Pharmaceutical
8.11.1 Company Details
8.11.2 Product Information
8.11.3 Hoffmann-La Roche/ Chugai Pharmaceutical Devic’s Syndrome (Neuromyelitis Optica) Treatment Production, Price, Cost, Gross Margin, and Revenue (2018-2020)
8.11.4 Main Business Overview
8.11.5 Hoffmann-La Roche/ Chugai Pharmaceutical News
8.12 MedImmune LLC
8.12.1 Company Details
8.12.2 Product Information
8.12.3 MedImmune LLC Devic’s Syndrome (Neuromyelitis Optica) Treatment Production, Price, Cost, Gross Margin, and Revenue (2018-2020)
8.12.4 Main Business Overview
8.12.5 MedImmune LLC News
8.13 RemeGen, Ltd.
8.13.1 Company Details
8.13.2 Product Information
8.13.3 RemeGen, Ltd. Devic’s Syndrome (Neuromyelitis Optica) Treatment Production, Price, Cost, Gross Margin, and Revenue (2018-2020)
8.13.4 Main Business Overview
8.13.5 RemeGen, Ltd. News
9 RESEARCH FINDINGS AND CONCLUSION
10 APPENDIX
LIST OF TABLES AND FIGURES
Figure Devic’s Syndrome (Neuromyelitis Optica) Treatment Picture
Figure Research Programs/Design for This Report
Figure Global Devic’s Syndrome (Neuromyelitis Optica) Treatment Market by Regions (2019)
Table Global Market Devic’s Syndrome (Neuromyelitis Optica) Treatment Comparison by Regions (M USD) 2019-2025
Table Global Devic’s Syndrome (Neuromyelitis Optica) Treatment Sales Growth (CAGR) (2019-2025) by Type
Figure Global Sales Market Share of Devic’s Syndrome (Neuromyelitis Optica) Treatment by Type in 2019
Figure Eculizumab Picture
Figure Methylprednisolone Picture
Figure Azathioprine Picture
Figure Mycophenolate Mofetil Picture
Figure Rituximab Picture
Table Global Devic’s Syndrome (Neuromyelitis Optica) Treatment Sales by Application (2019-2025)
Figure Global Devic’s Syndrome (Neuromyelitis Optica) Treatment Sales Market Share by Application in 2019
Figure Hospitals Picture
Figure Clinic Picture
Figure Others Picture
Table Global Devic’s Syndrome (Neuromyelitis Optica) Treatment Sales by Manufacturer (2018-2020)
Figure Global Devic’s Syndrome (Neuromyelitis Optica) Treatment Sales Market Share by Manufacturer in 2019
Table Global Devic’s Syndrome (Neuromyelitis Optica) Treatment Revenue by Manufacturer (2018-2020)
Figure Global Devic’s Syndrome (Neuromyelitis Optica) Treatment Revenue Market Share by Manufacturer in 2019
Table Global Devic’s Syndrome (Neuromyelitis Optica) Treatment Manufacturers Market Concentration Ratio (CR5 and HHI)
Figure Top 5 Devic’s Syndrome (Neuromyelitis Optica) Treatment Manufacturer (Revenue) Market Share in 2019
Figure Top 10 Devic’s Syndrome (Neuromyelitis Optica) Treatment Manufacturer (Revenue) Market Share in 2019
Table Date of Key Manufacturers Enter into Devic’s Syndrome (Neuromyelitis Optica) Treatment Market
Table Key Manufacturers Devic’s Syndrome (Neuromyelitis Optica) Treatment Product Type
Table Mergers & Acquisitions Planning
Table Market Opportunities in Next Few Years
Table Market Risks Analysis
Table Market Drivers
Table Key Players of Upstream Markets
Table Key Raw Materials
Figure Price Trend of Key Raw Materials
Table Key Suppliers of Raw Materials
Figure Manufacturing Cost Structure of Devic’s Syndrome (Neuromyelitis Optica) Treatment
Table Key Players of Upstream Markets
Figure Sales Channel
Table Global Devic’s Syndrome (Neuromyelitis Optica) Treatment Sales (K Units) by Region (2015-2020)
Table Global Devic’s Syndrome (Neuromyelitis Optica) Treatment Sales Market Share by Region (2015-2019)
Figure Global Devic’s Syndrome (Neuromyelitis Optica) Treatment Sales Market Share by Region (2015-2019)
Figure Global Devic’s Syndrome (Neuromyelitis Optica) Treatment Sales Market Share by Region in 2018
Table Global Devic’s Syndrome (Neuromyelitis Optica) Treatment Revenue (Million US$) by Region (2015-2020)
Table Global Devic’s Syndrome (Neuromyelitis Optica) Treatment Revenue Market Share by Region (2015-2020)
Figure Global Devic’s Syndrome (Neuromyelitis Optica) Treatment Revenue Market Share by Region (2015-2020)
Figure Global Devic’s Syndrome (Neuromyelitis Optica) Treatment Revenue Market Share by Region in 2019
Table Global Devic’s Syndrome (Neuromyelitis Optica) Treatment Sales (K Units), Revenue (Million US$), Price (USD/Unit) and Gross Margin (2015-2020)
Figure North America Devic’s Syndrome (Neuromyelitis Optica) Treatment Sales (K Units) Growth Rate (2015-2020)
Table North America Devic’s Syndrome (Neuromyelitis Optica) Treatment Sales (K Units), Revenue (Million US$), Price (USD/Unit) and Gross Margin (2015-2020)
Figure Europe Devic’s Syndrome (Neuromyelitis Optica) Treatment Sales (K Units) Growth Rate (2015-2020)
Table Europe Devic’s Syndrome (Neuromyelitis Optica) Treatment Sales (K Units), Revenue (Million US$), Price (USD/Unit) and Gross Margin (2015-2020)
Figure Japan Devic’s Syndrome (Neuromyelitis Optica) Treatment Sales (K Units) Growth Rate (2015-2020)
Table Japan Devic’s Syndrome (Neuromyelitis Optica) Treatment Sales (K Units), Revenue (Million US$), Price (USD/Unit) and Gross Margin (2015-2020)
Figure China Devic’s Syndrome (Neuromyelitis Optica) Treatment Sales (K Units) Growth Rate (2015-2020)
Table China Devic’s Syndrome (Neuromyelitis Optica) Treatment Sales (K Units), Revenue (Million US$), Price (USD/Unit) and Gross Margin (2015-2020)
Table Global Devic’s Syndrome (Neuromyelitis Optica) Treatment Sales by Type (2015-2020)
Table Global Devic’s Syndrome (Neuromyelitis Optica) Treatment Sales Market Share by Type (2015-2020)
Figure Global Devic’s Syndrome (Neuromyelitis Optica) Treatment Sales Market Share by Type in 2019
Table Global Devic’s Syndrome (Neuromyelitis Optica) Treatment Revenue by Type (2015-2020)
Table Global Devic’s Syndrome (Neuromyelitis Optica) Treatment Revenue Market Share by Type (2015-2020)
Figure Global Devic’s Syndrome (Neuromyelitis Optica) Treatment Revenue Market Share by Type in 2019
Figure Global Eculizumab Sales Growth Rate (2015-2020)
Figure Global Eculizumab Price (2015-2020)
Figure Global Methylprednisolone Sales Growth Rate (2015-2020)
Figure Global Methylprednisolone Price (2015-2020)
Figure Global Azathioprine Sales Growth Rate (2015-2020)
Figure Global Azathioprine Price (2015-2020)
Figure Global Mycophenolate Mofetil Sales Growth Rate (2015-2020)
Figure Global Mycophenolate Mofetil Price (2015-2020)
Figure Global Rituximab Sales Growth Rate (2015-2020)
Figure Global Rituximab Price (2015-2020)
Table Global Devic’s Syndrome (Neuromyelitis Optica) Treatment Sales by Application (2015-2020)
Table Global Devic’s Syndrome (Neuromyelitis Optica) Treatment Sales Market Share by Application (2015-2020)
Figure Global Devic’s Syndrome (Neuromyelitis Optica) Treatment Sales Market Share by Application in 2019
Figure Global Hospitals Sales Growth Rate (2015-2020)
Figure Global Clinic Sales Growth Rate (2015-2020)
Figure Global Others Sales Growth Rate (2015-2020)
Figure Global Devic’s Syndrome (Neuromyelitis Optica) Treatment Production (K Units) Growth Rate Forecast (2020-2025)
Figure Global Devic’s Syndrome (Neuromyelitis Optica) Treatment Revenue (Million US$) Growth Rate Forecast (2020-2025)
Figure Global Devic’s Syndrome (Neuromyelitis Optica) Treatment Price and Trend Forecast (2020-2025)
Table Global Devic’s Syndrome (Neuromyelitis Optica) Treatment Sales (K Units) Forecast by Region (2020-2025)
Figure Global Devic’s Syndrome (Neuromyelitis Optica) Treatment Production Market Share Forecast by Region (2020-2025)
Figure North America Devic’s Syndrome (Neuromyelitis Optica) Treatment Sales (K Units) Growth Rate Forecast (2020-2025)
Figure North America Devic’s Syndrome (Neuromyelitis Optica) Treatment Revenue (Million US$) Growth Rate Forecast (2020-2025)
Figure Europe Devic’s Syndrome (Neuromyelitis Optica) Treatment Sales (K Units) Growth Rate Forecast (2020-2025)
Figure Europe Devic’s Syndrome (Neuromyelitis Optica) Treatment Revenue (Million US$) Growth Rate Forecast (2020-2025)
Figure Japan Devic’s Syndrome (Neuromyelitis Optica) Treatment Production (K Units) Growth Rate Forecast (2020-2025)
Figure Japan Devic’s Syndrome (Neuromyelitis Optica) Treatment Revenue (Million US$) Growth Rate Forecast (2020-2025)
Figure China Devic’s Syndrome (Neuromyelitis Optica) Treatment Production (K Units) Growth Rate Forecast (2020-2025)
Figure China Devic’s Syndrome (Neuromyelitis Optica) Treatment Revenue (Million US$) Growth Rate Forecast (2020-2025)
Table Alexion Pharmaceuticals, Inc. Company Profile
Figure Devic’s Syndrome (Neuromyelitis Optica) Treatment Product Picture and Specifications of Alexion Pharmaceuticals, Inc.
Table Devic’s Syndrome (Neuromyelitis Optica) Treatment Production, Price, Revenue and Gross Margin of 2018-2020
Figure Alexion Pharmaceuticals, Inc. Devic’s Syndrome (Neuromyelitis Optica) Treatment Market Share (2018-2020)
Table Alexion Pharmaceuticals, Inc. Main Business
Table Alexion Pharmaceuticals, Inc. Recent Development
Table Sandoz Inc. (Novartis) Company Profile
Figure Devic’s Syndrome (Neuromyelitis Optica) Treatment Product Picture and Specifications of Sandoz Inc. (Novartis)
Table Devic’s Syndrome (Neuromyelitis Optica) Treatment Production, Price, Revenue and Gross Margin of 2018-2020
Figure Sandoz Inc. (Novartis) Devic’s Syndrome (Neuromyelitis Optica) Treatment Market Share (2018-2020)
Table Sandoz Inc. (Novartis) Main Business
Table Sandoz Inc. (Novartis) Recent Development
Table Pharmacia & Upjohn (a subsidary of Pfizer) Company Profile
Figure Devic’s Syndrome (Neuromyelitis Optica) Treatment Product Picture and Specifications of Pharmacia & Upjohn (a subsidary of Pfizer)
Table Devic’s Syndrome (Neuromyelitis Optica) Treatment Production, Price, Revenue and Gross Margin of 2018-2020
Figure Pharmacia & Upjohn (a subsidary of Pfizer) Devic’s Syndrome (Neuromyelitis Optica) Treatment Market Share (2018-2020)
Table Pharmacia & Upjohn (a subsidary of Pfizer) Main Business
Table Pharmacia & Upjohn (a subsidary of Pfizer) Recent Development
Table Teva Pharmaceuticals Company Profile
Figure Devic’s Syndrome (Neuromyelitis Optica) Treatment Product Picture and Specifications of Teva Pharmaceuticals
Table Devic’s Syndrome (Neuromyelitis Optica) Treatment Production, Price, Revenue and Gross Margin of 2018-2020
Figure Teva Pharmaceuticals Devic’s Syndrome (Neuromyelitis Optica) Treatment Market Share (2018-2020)
Table Teva Pharmaceuticals Main Business
Table Teva Pharmaceuticals Recent Development
Table Zydus Pharmaceuticals, Inc. Company Profile
Figure Devic’s Syndrome (Neuromyelitis Optica) Treatment Product Picture and Specifications of Zydus Pharmaceuticals, Inc.
Table Devic’s Syndrome (Neuromyelitis Optica) Treatment Production, Price, Revenue and Gross Margin of 2018-2020
Figure Zydus Pharmaceuticals, Inc. Devic’s Syndrome (Neuromyelitis Optica) Treatment Market Share (2018-2020)
Table Zydus Pharmaceuticals, Inc. Main Business
Table Zydus Pharmaceuticals, Inc. Recent Development
Table Fresenius Kabi AG Company Profile
Figure Devic’s Syndrome (Neuromyelitis Optica) Treatment Product Picture and Specifications of Fresenius Kabi AG
Table Devic’s Syndrome (Neuromyelitis Optica) Treatment Production, Price, Revenue and Gross Margin of 2018-2020
Figure Fresenius Kabi AG Devic’s Syndrome (Neuromyelitis Optica) Treatment Market Share (2018-2020)
Table Fresenius Kabi AG Main Business
Table Fresenius Kabi AG Recent Development
Table Mylan Pharmaceuticals, Inc. Company Profile
Figure Devic’s Syndrome (Neuromyelitis Optica) Treatment Product Picture and Specifications of Mylan Pharmaceuticals, Inc.
Table Devic’s Syndrome (Neuromyelitis Optica) Treatment Production, Price, Revenue and Gross Margin of 2018-2020
Figure Mylan Pharmaceuticals, Inc. Devic’s Syndrome (Neuromyelitis Optica) Treatment Market Share (2018-2020)
Table Mylan Pharmaceuticals, Inc. Main Business
Table Mylan Pharmaceuticals, Inc. Recent Development
Table Sagent Pharmaceuticals, Inc. Company Profile
Figure Devic’s Syndrome (Neuromyelitis Optica) Treatment Product Picture and Specifications of Sagent Pharmaceuticals, Inc.
Table Devic’s Syndrome (Neuromyelitis Optica) Treatment Production, Price, Revenue and Gross Margin of 2018-2020
Figure Sagent Pharmaceuticals, Inc. Devic’s Syndrome (Neuromyelitis Optica) Treatment Market Share (2018-2020)
Table Sagent Pharmaceuticals, Inc. Main Business
Table Sagent Pharmaceuticals, Inc. Recent Development
Table Lupin Ltd. Company Profile
Figure Devic’s Syndrome (Neuromyelitis Optica) Treatment Product Picture and Specifications of Lupin Ltd.
Table Devic’s Syndrome (Neuromyelitis Optica) Treatment Production, Price, Revenue and Gross Margin of 2018-2020
Figure Lupin Ltd. Devic’s Syndrome (Neuromyelitis Optica) Treatment Market Share (2018-2020)
Table Lupin Ltd. Main Business
Table Lupin Ltd. Recent Development
Table Alkem Laboratories Ltd. Company Profile
Figure Devic’s Syndrome (Neuromyelitis Optica) Treatment Product Picture and Specifications of Alkem Laboratories Ltd.
Table Devic’s Syndrome (Neuromyelitis Optica) Treatment Production, Price, Revenue and Gross Margin of 2018-2020
Figure Alkem Laboratories Ltd. Devic’s Syndrome (Neuromyelitis Optica) Treatment Market Share (2018-2020)
Table Alkem Laboratories Ltd. Main Business
Table Alkem Laboratories Ltd. Recent Development
Table Hoffmann-La Roche/ Chugai Pharmaceutical Company Profile
Figure Devic’s Syndrome (Neuromyelitis Optica) Treatment Product Picture and Specifications of Hoffmann-La Roche/ Chugai Pharmaceutical
Table Devic’s Syndrome (Neuromyelitis Optica) Treatment Production, Price, Revenue and Gross Margin of 2018-2020
Figure Hoffmann-La Roche/ Chugai Pharmaceutical Devic’s Syndrome (Neuromyelitis Optica) Treatment Market Share (2018-2020)
Table Hoffmann-La Roche/ Chugai Pharmaceutical Main Business
Table Hoffmann-La Roche/ Chugai Pharmaceutical Recent Development
Table MedImmune LLC Company Profile
Figure Devic’s Syndrome (Neuromyelitis Optica) Treatment Product Picture and Specifications of MedImmune LLC
Table Devic’s Syndrome (Neuromyelitis Optica) Treatment Production, Price, Revenue and Gross Margin of 2018-2020
Figure MedImmune LLC Devic’s Syndrome (Neuromyelitis Optica) Treatment Market Share (2018-2020)
Table MedImmune LLC Main Business
Table MedImmune LLC Recent Development
Table RemeGen, Ltd. Company Profile
Figure Devic’s Syndrome (Neuromyelitis Optica) Treatment Product Picture and Specifications of RemeGen, Ltd.
Table Devic’s Syndrome (Neuromyelitis Optica) Treatment Production, Price, Revenue and Gross Margin of 2018-2020
Figure RemeGen, Ltd. Devic’s Syndrome (Neuromyelitis Optica) Treatment Market Share (2018-2020)
Table RemeGen, Ltd. Main Business
Table RemeGen, Ltd. Recent Development
Table of Appendix
Figure Devic’s Syndrome (Neuromyelitis Optica) Treatment Picture
Figure Research Programs/Design for This Report
Figure Global Devic’s Syndrome (Neuromyelitis Optica) Treatment Market by Regions (2019)
Table Global Market Devic’s Syndrome (Neuromyelitis Optica) Treatment Comparison by Regions (M USD) 2019-2025
Table Global Devic’s Syndrome (Neuromyelitis Optica) Treatment Sales Growth (CAGR) (2019-2025) by Type
Figure Global Sales Market Share of Devic’s Syndrome (Neuromyelitis Optica) Treatment by Type in 2019
Figure Eculizumab Picture
Figure Methylprednisolone Picture
Figure Azathioprine Picture
Figure Mycophenolate Mofetil Picture
Figure Rituximab Picture
Table Global Devic’s Syndrome (Neuromyelitis Optica) Treatment Sales by Application (2019-2025)
Figure Global Devic’s Syndrome (Neuromyelitis Optica) Treatment Sales Market Share by Application in 2019
Figure Hospitals Picture
Figure Clinic Picture
Figure Others Picture
Table Global Devic’s Syndrome (Neuromyelitis Optica) Treatment Sales by Manufacturer (2018-2020)
Figure Global Devic’s Syndrome (Neuromyelitis Optica) Treatment Sales Market Share by Manufacturer in 2019
Table Global Devic’s Syndrome (Neuromyelitis Optica) Treatment Revenue by Manufacturer (2018-2020)
Figure Global Devic’s Syndrome (Neuromyelitis Optica) Treatment Revenue Market Share by Manufacturer in 2019
Table Global Devic’s Syndrome (Neuromyelitis Optica) Treatment Manufacturers Market Concentration Ratio (CR5 and HHI)
Figure Top 5 Devic’s Syndrome (Neuromyelitis Optica) Treatment Manufacturer (Revenue) Market Share in 2019
Figure Top 10 Devic’s Syndrome (Neuromyelitis Optica) Treatment Manufacturer (Revenue) Market Share in 2019
Table Date of Key Manufacturers Enter into Devic’s Syndrome (Neuromyelitis Optica) Treatment Market
Table Key Manufacturers Devic’s Syndrome (Neuromyelitis Optica) Treatment Product Type
Table Mergers & Acquisitions Planning
Table Market Opportunities in Next Few Years
Table Market Risks Analysis
Table Market Drivers
Table Key Players of Upstream Markets
Table Key Raw Materials
Figure Price Trend of Key Raw Materials
Table Key Suppliers of Raw Materials
Figure Manufacturing Cost Structure of Devic’s Syndrome (Neuromyelitis Optica) Treatment
Table Key Players of Upstream Markets
Figure Sales Channel
Table Global Devic’s Syndrome (Neuromyelitis Optica) Treatment Sales (K Units) by Region (2015-2020)
Table Global Devic’s Syndrome (Neuromyelitis Optica) Treatment Sales Market Share by Region (2015-2019)
Figure Global Devic’s Syndrome (Neuromyelitis Optica) Treatment Sales Market Share by Region (2015-2019)
Figure Global Devic’s Syndrome (Neuromyelitis Optica) Treatment Sales Market Share by Region in 2018
Table Global Devic’s Syndrome (Neuromyelitis Optica) Treatment Revenue (Million US$) by Region (2015-2020)
Table Global Devic’s Syndrome (Neuromyelitis Optica) Treatment Revenue Market Share by Region (2015-2020)
Figure Global Devic’s Syndrome (Neuromyelitis Optica) Treatment Revenue Market Share by Region (2015-2020)
Figure Global Devic’s Syndrome (Neuromyelitis Optica) Treatment Revenue Market Share by Region in 2019
Table Global Devic’s Syndrome (Neuromyelitis Optica) Treatment Sales (K Units), Revenue (Million US$), Price (USD/Unit) and Gross Margin (2015-2020)
Figure North America Devic’s Syndrome (Neuromyelitis Optica) Treatment Sales (K Units) Growth Rate (2015-2020)
Table North America Devic’s Syndrome (Neuromyelitis Optica) Treatment Sales (K Units), Revenue (Million US$), Price (USD/Unit) and Gross Margin (2015-2020)
Figure Europe Devic’s Syndrome (Neuromyelitis Optica) Treatment Sales (K Units) Growth Rate (2015-2020)
Table Europe Devic’s Syndrome (Neuromyelitis Optica) Treatment Sales (K Units), Revenue (Million US$), Price (USD/Unit) and Gross Margin (2015-2020)
Figure Japan Devic’s Syndrome (Neuromyelitis Optica) Treatment Sales (K Units) Growth Rate (2015-2020)
Table Japan Devic’s Syndrome (Neuromyelitis Optica) Treatment Sales (K Units), Revenue (Million US$), Price (USD/Unit) and Gross Margin (2015-2020)
Figure China Devic’s Syndrome (Neuromyelitis Optica) Treatment Sales (K Units) Growth Rate (2015-2020)
Table China Devic’s Syndrome (Neuromyelitis Optica) Treatment Sales (K Units), Revenue (Million US$), Price (USD/Unit) and Gross Margin (2015-2020)
Table Global Devic’s Syndrome (Neuromyelitis Optica) Treatment Sales by Type (2015-2020)
Table Global Devic’s Syndrome (Neuromyelitis Optica) Treatment Sales Market Share by Type (2015-2020)
Figure Global Devic’s Syndrome (Neuromyelitis Optica) Treatment Sales Market Share by Type in 2019
Table Global Devic’s Syndrome (Neuromyelitis Optica) Treatment Revenue by Type (2015-2020)
Table Global Devic’s Syndrome (Neuromyelitis Optica) Treatment Revenue Market Share by Type (2015-2020)
Figure Global Devic’s Syndrome (Neuromyelitis Optica) Treatment Revenue Market Share by Type in 2019
Figure Global Eculizumab Sales Growth Rate (2015-2020)
Figure Global Eculizumab Price (2015-2020)
Figure Global Methylprednisolone Sales Growth Rate (2015-2020)
Figure Global Methylprednisolone Price (2015-2020)
Figure Global Azathioprine Sales Growth Rate (2015-2020)
Figure Global Azathioprine Price (2015-2020)
Figure Global Mycophenolate Mofetil Sales Growth Rate (2015-2020)
Figure Global Mycophenolate Mofetil Price (2015-2020)
Figure Global Rituximab Sales Growth Rate (2015-2020)
Figure Global Rituximab Price (2015-2020)
Table Global Devic’s Syndrome (Neuromyelitis Optica) Treatment Sales by Application (2015-2020)
Table Global Devic’s Syndrome (Neuromyelitis Optica) Treatment Sales Market Share by Application (2015-2020)
Figure Global Devic’s Syndrome (Neuromyelitis Optica) Treatment Sales Market Share by Application in 2019
Figure Global Hospitals Sales Growth Rate (2015-2020)
Figure Global Clinic Sales Growth Rate (2015-2020)
Figure Global Others Sales Growth Rate (2015-2020)
Figure Global Devic’s Syndrome (Neuromyelitis Optica) Treatment Production (K Units) Growth Rate Forecast (2020-2025)
Figure Global Devic’s Syndrome (Neuromyelitis Optica) Treatment Revenue (Million US$) Growth Rate Forecast (2020-2025)
Figure Global Devic’s Syndrome (Neuromyelitis Optica) Treatment Price and Trend Forecast (2020-2025)
Table Global Devic’s Syndrome (Neuromyelitis Optica) Treatment Sales (K Units) Forecast by Region (2020-2025)
Figure Global Devic’s Syndrome (Neuromyelitis Optica) Treatment Production Market Share Forecast by Region (2020-2025)
Figure North America Devic’s Syndrome (Neuromyelitis Optica) Treatment Sales (K Units) Growth Rate Forecast (2020-2025)
Figure North America Devic’s Syndrome (Neuromyelitis Optica) Treatment Revenue (Million US$) Growth Rate Forecast (2020-2025)
Figure Europe Devic’s Syndrome (Neuromyelitis Optica) Treatment Sales (K Units) Growth Rate Forecast (2020-2025)
Figure Europe Devic’s Syndrome (Neuromyelitis Optica) Treatment Revenue (Million US$) Growth Rate Forecast (2020-2025)
Figure Japan Devic’s Syndrome (Neuromyelitis Optica) Treatment Production (K Units) Growth Rate Forecast (2020-2025)
Figure Japan Devic’s Syndrome (Neuromyelitis Optica) Treatment Revenue (Million US$) Growth Rate Forecast (2020-2025)
Figure China Devic’s Syndrome (Neuromyelitis Optica) Treatment Production (K Units) Growth Rate Forecast (2020-2025)
Figure China Devic’s Syndrome (Neuromyelitis Optica) Treatment Revenue (Million US$) Growth Rate Forecast (2020-2025)
Table Alexion Pharmaceuticals, Inc. Company Profile
Figure Devic’s Syndrome (Neuromyelitis Optica) Treatment Product Picture and Specifications of Alexion Pharmaceuticals, Inc.
Table Devic’s Syndrome (Neuromyelitis Optica) Treatment Production, Price, Revenue and Gross Margin of 2018-2020
Figure Alexion Pharmaceuticals, Inc. Devic’s Syndrome (Neuromyelitis Optica) Treatment Market Share (2018-2020)
Table Alexion Pharmaceuticals, Inc. Main Business
Table Alexion Pharmaceuticals, Inc. Recent Development
Table Sandoz Inc. (Novartis) Company Profile
Figure Devic’s Syndrome (Neuromyelitis Optica) Treatment Product Picture and Specifications of Sandoz Inc. (Novartis)
Table Devic’s Syndrome (Neuromyelitis Optica) Treatment Production, Price, Revenue and Gross Margin of 2018-2020
Figure Sandoz Inc. (Novartis) Devic’s Syndrome (Neuromyelitis Optica) Treatment Market Share (2018-2020)
Table Sandoz Inc. (Novartis) Main Business
Table Sandoz Inc. (Novartis) Recent Development
Table Pharmacia & Upjohn (a subsidary of Pfizer) Company Profile
Figure Devic’s Syndrome (Neuromyelitis Optica) Treatment Product Picture and Specifications of Pharmacia & Upjohn (a subsidary of Pfizer)
Table Devic’s Syndrome (Neuromyelitis Optica) Treatment Production, Price, Revenue and Gross Margin of 2018-2020
Figure Pharmacia & Upjohn (a subsidary of Pfizer) Devic’s Syndrome (Neuromyelitis Optica) Treatment Market Share (2018-2020)
Table Pharmacia & Upjohn (a subsidary of Pfizer) Main Business
Table Pharmacia & Upjohn (a subsidary of Pfizer) Recent Development
Table Teva Pharmaceuticals Company Profile
Figure Devic’s Syndrome (Neuromyelitis Optica) Treatment Product Picture and Specifications of Teva Pharmaceuticals
Table Devic’s Syndrome (Neuromyelitis Optica) Treatment Production, Price, Revenue and Gross Margin of 2018-2020
Figure Teva Pharmaceuticals Devic’s Syndrome (Neuromyelitis Optica) Treatment Market Share (2018-2020)
Table Teva Pharmaceuticals Main Business
Table Teva Pharmaceuticals Recent Development
Table Zydus Pharmaceuticals, Inc. Company Profile
Figure Devic’s Syndrome (Neuromyelitis Optica) Treatment Product Picture and Specifications of Zydus Pharmaceuticals, Inc.
Table Devic’s Syndrome (Neuromyelitis Optica) Treatment Production, Price, Revenue and Gross Margin of 2018-2020
Figure Zydus Pharmaceuticals, Inc. Devic’s Syndrome (Neuromyelitis Optica) Treatment Market Share (2018-2020)
Table Zydus Pharmaceuticals, Inc. Main Business
Table Zydus Pharmaceuticals, Inc. Recent Development
Table Fresenius Kabi AG Company Profile
Figure Devic’s Syndrome (Neuromyelitis Optica) Treatment Product Picture and Specifications of Fresenius Kabi AG
Table Devic’s Syndrome (Neuromyelitis Optica) Treatment Production, Price, Revenue and Gross Margin of 2018-2020
Figure Fresenius Kabi AG Devic’s Syndrome (Neuromyelitis Optica) Treatment Market Share (2018-2020)
Table Fresenius Kabi AG Main Business
Table Fresenius Kabi AG Recent Development
Table Mylan Pharmaceuticals, Inc. Company Profile
Figure Devic’s Syndrome (Neuromyelitis Optica) Treatment Product Picture and Specifications of Mylan Pharmaceuticals, Inc.
Table Devic’s Syndrome (Neuromyelitis Optica) Treatment Production, Price, Revenue and Gross Margin of 2018-2020
Figure Mylan Pharmaceuticals, Inc. Devic’s Syndrome (Neuromyelitis Optica) Treatment Market Share (2018-2020)
Table Mylan Pharmaceuticals, Inc. Main Business
Table Mylan Pharmaceuticals, Inc. Recent Development
Table Sagent Pharmaceuticals, Inc. Company Profile
Figure Devic’s Syndrome (Neuromyelitis Optica) Treatment Product Picture and Specifications of Sagent Pharmaceuticals, Inc.
Table Devic’s Syndrome (Neuromyelitis Optica) Treatment Production, Price, Revenue and Gross Margin of 2018-2020
Figure Sagent Pharmaceuticals, Inc. Devic’s Syndrome (Neuromyelitis Optica) Treatment Market Share (2018-2020)
Table Sagent Pharmaceuticals, Inc. Main Business
Table Sagent Pharmaceuticals, Inc. Recent Development
Table Lupin Ltd. Company Profile
Figure Devic’s Syndrome (Neuromyelitis Optica) Treatment Product Picture and Specifications of Lupin Ltd.
Table Devic’s Syndrome (Neuromyelitis Optica) Treatment Production, Price, Revenue and Gross Margin of 2018-2020
Figure Lupin Ltd. Devic’s Syndrome (Neuromyelitis Optica) Treatment Market Share (2018-2020)
Table Lupin Ltd. Main Business
Table Lupin Ltd. Recent Development
Table Alkem Laboratories Ltd. Company Profile
Figure Devic’s Syndrome (Neuromyelitis Optica) Treatment Product Picture and Specifications of Alkem Laboratories Ltd.
Table Devic’s Syndrome (Neuromyelitis Optica) Treatment Production, Price, Revenue and Gross Margin of 2018-2020
Figure Alkem Laboratories Ltd. Devic’s Syndrome (Neuromyelitis Optica) Treatment Market Share (2018-2020)
Table Alkem Laboratories Ltd. Main Business
Table Alkem Laboratories Ltd. Recent Development
Table Hoffmann-La Roche/ Chugai Pharmaceutical Company Profile
Figure Devic’s Syndrome (Neuromyelitis Optica) Treatment Product Picture and Specifications of Hoffmann-La Roche/ Chugai Pharmaceutical
Table Devic’s Syndrome (Neuromyelitis Optica) Treatment Production, Price, Revenue and Gross Margin of 2018-2020
Figure Hoffmann-La Roche/ Chugai Pharmaceutical Devic’s Syndrome (Neuromyelitis Optica) Treatment Market Share (2018-2020)
Table Hoffmann-La Roche/ Chugai Pharmaceutical Main Business
Table Hoffmann-La Roche/ Chugai Pharmaceutical Recent Development
Table MedImmune LLC Company Profile
Figure Devic’s Syndrome (Neuromyelitis Optica) Treatment Product Picture and Specifications of MedImmune LLC
Table Devic’s Syndrome (Neuromyelitis Optica) Treatment Production, Price, Revenue and Gross Margin of 2018-2020
Figure MedImmune LLC Devic’s Syndrome (Neuromyelitis Optica) Treatment Market Share (2018-2020)
Table MedImmune LLC Main Business
Table MedImmune LLC Recent Development
Table RemeGen, Ltd. Company Profile
Figure Devic’s Syndrome (Neuromyelitis Optica) Treatment Product Picture and Specifications of RemeGen, Ltd.
Table Devic’s Syndrome (Neuromyelitis Optica) Treatment Production, Price, Revenue and Gross Margin of 2018-2020
Figure RemeGen, Ltd. Devic’s Syndrome (Neuromyelitis Optica) Treatment Market Share (2018-2020)
Table RemeGen, Ltd. Main Business
Table RemeGen, Ltd. Recent Development
Table of Appendix
